⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WHWK News
Whitehawk Therapeutics, Inc. Common Stock
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
prnewswire.com
WHWK
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
prnewswire.com
WHWK
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
prnewswire.com
WHWK
Form 8-K
sec.gov
WHWK
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
prnewswire.com
WHWK
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
prnewswire.com
WHWK
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
prnewswire.com
WHWK
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
prnewswire.com
WHWK
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
prnewswire.com
WHWK
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
prnewswire.com
WHWK